238 related articles for article (PubMed ID: 22338554)
1. OTc prolongation and torsade de pointes ventricular tachycardia in a small dose voriconazole therapy.
Elbey MA; Cil H; Onturk E; Islamoglu Y
Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):100-2. PubMed ID: 22338554
[TBL] [Abstract][Full Text] [Related]
2. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
[TBL] [Abstract][Full Text] [Related]
3. Torsades de pointes associated with voriconazole use.
Philips JA; Marty FM; Stone RM; Koplan BA; Katz JT; Baden LR
Transpl Infect Dis; 2007 Mar; 9(1):33-6. PubMed ID: 17313469
[TBL] [Abstract][Full Text] [Related]
4. Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect.
Alkan Y; Haefeli WE; Burhenne J; Stein J; Yaniv I; Shalit I
Clin Infect Dis; 2004 Sep; 39(6):e49-52. PubMed ID: 15472801
[TBL] [Abstract][Full Text] [Related]
5. Inherited long QT syndrome revealed by antifungals drug-drug interaction.
Eiden C; Peyrière H; Tichit R; Cociglio M; Amedro P; Blayac JP; Margueritte G; Hillaire-Buys D
J Clin Pharm Ther; 2007 Jun; 32(3):321-4. PubMed ID: 17489884
[TBL] [Abstract][Full Text] [Related]
6. Voriconazole-induced QT interval prolongation and torsades de pointes.
Aypar E; Kendirli T; Tutar E; Çiftçi E; Ince E; Ileri T; Atalay S
Pediatr Int; 2011 Oct; 53(5):761-763. PubMed ID: 21955009
[No Abstract] [Full Text] [Related]
7. Long QTc interval and torsade de pointes caused by fluconazole.
Pham CP; de Feiter PW; van der Kuy PH; van Mook WN
Ann Pharmacother; 2006; 40(7-8):1456-61. PubMed ID: 16849620
[TBL] [Abstract][Full Text] [Related]
8. A case series of drug-induced long QT syndrome and Torsade de Pointes.
Tong KL; Lau YS; Teo WS
Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
[TBL] [Abstract][Full Text] [Related]
9. QT interval prolongation, torsade de pointes and renal disease.
Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
[TBL] [Abstract][Full Text] [Related]
10. QT interval prolongation and torsade de pointes.
Patanè S; Marte F; Di Bella G
Int J Cardiol; 2009 Jan; 131(2):e51-3. PubMed ID: 17689729
[TBL] [Abstract][Full Text] [Related]
11. Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
Zeuli JD; Wilson JW; Estes LL
Antimicrob Agents Chemother; 2013 Mar; 57(3):1121-7. PubMed ID: 23229485
[TBL] [Abstract][Full Text] [Related]
12. A case of torsades de pointes induced by severe QT prolongation after an overdose of eperisone and triazolam in a patient receiving nifedipine.
Yamagiwa T; Amino M; Morita S; Yamamoto R; Saito T; Inokuchi S
Clin Toxicol (Phila); 2010 Feb; 48(2):149-52. PubMed ID: 20199131
[TBL] [Abstract][Full Text] [Related]
13. Torsade de pointes during sevoflurane anesthesia and fluconazole infusion in a patient with long QT syndrome. A case report.
Tacken MC; Bracke FA; Van Zundert AA
Acta Anaesthesiol Belg; 2011; 62(2):105-8. PubMed ID: 21919379
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics of 52 patients with torsade de points associated with acquired QT prolongation].
Song L; Yang YM; Zhu J
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Apr; 39(4):293-6. PubMed ID: 21624301
[TBL] [Abstract][Full Text] [Related]
15. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
[TBL] [Abstract][Full Text] [Related]
17. The perfect storm: Torsades de Pointes in a child with leukemia.
Bagatell R; Hainstock M; Lowe MC; Barber BJ; Samson RA
Pediatr Blood Cancer; 2007 Dec; 49(7):996-9. PubMed ID: 16333840
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
Ahmad K; Dorian P
Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320
[TBL] [Abstract][Full Text] [Related]
19. Citalopram induced torsade de pointes, a rare life threatening side effect.
Kanjanauthai S; Kanluen T; Chareonthaitawee P
Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753
[TBL] [Abstract][Full Text] [Related]
20. Diphenhydramine induced QT prolongation and torsade de pointes: An uncommon effect of a common drug.
Husain Z; Hussain K; Nair R; Steinman R
Cardiol J; 2010; 17(5):509-11. PubMed ID: 20865683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
